Showing results (171-180 of 442) with videos related to

Sort By:
Pageof 45
Inflammatory Bowel Diseases|June 30, 2007
Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitisGilaad G Kaplan, Steven J Heitman, Robert J Hilsden, et al.
World Journal of Gastroenterology|January 30, 2015
Colectomy is a risk factor for venous thromboembolism in ulcerative colitisGilaad G Kaplan, Allen Lim, Cynthia H Seow, et al.
Advances in Therapy|January 3, 2024
Safety of Upadacitinib in Immune-Mediated Inflammatory Diseases: Systematic Literature Review of Indirect and Direct Treatment Comparisons of Randomized Controlled TrialsEduardo Mysler, Gerd R Burmester, Christopher D Saffore, et al.
Gastroenterology|June 10, 2015
Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based StudiesSunny Singh, Ahmed Al-Darmaki, Alexandra D Frolkis, et al.
Canadian Journal of Gastroenterology & Hepatology|February 17, 2025
Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World DataDavid C Sealey, Kai Fai Ho, Z Christina Zhou, et al.
Journal of the Canadian Association of Gastroenterology|April 15, 2021
Differential Effect of Genetic Burden on Disease Phenotypes in Crohn's Disease and Ulcerative Colitis in a Canadian CohortJack X Q Pang, Hengameh Kheirkhahrahimabadi, Sunint Bindra, et al.
Inflammatory Bowel Diseases|September 18, 2014
Colorectal cancer surveillance in patients with inflammatory bowel disease and primary sclerosing cholangitis: an economic evaluationMaría E Negrón, Gilaad G Kaplan, Herman W Barkema, et al.
The American Journal of Gastroenterology|October 29, 2014
Funding a smoking cessation program for Crohn's disease: an economic evaluationStephanie Coward, Steven J Heitman, Fiona Clement, et al.
Inflammatory Bowel Diseases|February 2, 2017
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysisStephanie Coward, M Ellen Kuenzig, Glen Hazlewood, et al.
Inflammatory Bowel Diseases|July 28, 2018
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis: RepublishedStephanie Coward, M Ellen Kuenzig, Glen Hazlewood, et al.
Pageof 45